235 related articles for article (PubMed ID: 16360448)
1. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer.
Brassell SA; Kao TC; Sun L; Moul JW
Urology; 2005 Dec; 66(6):1229-33. PubMed ID: 16360448
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure.
Radwan MH; Yan Y; Luly JR; Figenshau RS; Brandes SB; Bhayani SB; Bullock AD; Liefu Y; Andriole GL; Kibel AS
Urology; 2007 Jun; 69(6):1121-7. PubMed ID: 17572199
[TBL] [Abstract][Full Text] [Related]
3. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
Freedland SJ; Kane CJ; Presti JC; Terris MK; Amling CL; Dorey F; Aronson WJ
J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
[TBL] [Abstract][Full Text] [Related]
4. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
Jones TD; Koch MO; Bunde PJ; Cheng L
BJU Int; 2006 Mar; 97(3):480-4. PubMed ID: 16469012
[TBL] [Abstract][Full Text] [Related]
5. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L
Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
[TBL] [Abstract][Full Text] [Related]
7. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
8. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
[TBL] [Abstract][Full Text] [Related]
9. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.
Vis AN; Schröder FH; van der Kwast TH
Eur Urol; 2006 Aug; 50(2):258-65. PubMed ID: 16413660
[TBL] [Abstract][Full Text] [Related]
10. Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer.
Ingenito AC; Ennis RD; Hsu IC; Begg MD; Benson MC; Schiff PB
Urology; 1997 Jul; 50(1):73-8. PubMed ID: 9218022
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
12. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
13. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence.
Marks RA; Lin H; Koch MO; Cheng L
Am J Surg Pathol; 2007 Jun; 31(6):877-81. PubMed ID: 17527074
[TBL] [Abstract][Full Text] [Related]
14. The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration.
Monda JM; Myers RP; Bostwick DG; Oesterling JE
Urology; 1995 Jul; 46(1):62-4. PubMed ID: 7541588
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy.
Naya Y; Okihara K; Evans RB; Babaian RJ
Urology; 2005 Aug; 66(2):350-5. PubMed ID: 16040095
[TBL] [Abstract][Full Text] [Related]
16. [A study on parameters to predict tumor volume for stage T1c prostate cancers of Gleason score 6 or less].
Shichiri Y; Egawa S; Kamoto T; Kakehi Y; Ogawa O; Yoshida O; Sumiyoshi Y; Akakura K; Arai Y
Hinyokika Kiyo; 2000 Nov; 46(11):785-90. PubMed ID: 11193298
[TBL] [Abstract][Full Text] [Related]
17. [Total PSA, PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer].
Liu S; Lü JJ; Fu Q; Zhang H; Gao DX; Liu Z
Zhonghua Nan Ke Xue; 2010 May; 16(5):415-9. PubMed ID: 20684321
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
[TBL] [Abstract][Full Text] [Related]
19. [Predicting factors of tumor organ-confinement in adenocarcinoma of the prostate].
Borque Fernando A; Allepuz Losa C; Del Agua Arias C; Valdivia Navarro P; Ascaso Cornago I; Rioja Sanz LA
Actas Urol Esp; 1997 Oct; 21(9):890-7. PubMed ID: 9471872
[TBL] [Abstract][Full Text] [Related]
20. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
Custovic Z; Kraus O; Tomaskovic I; Tarle M
Anticancer Res; 2007; 27(4C):2817-21. PubMed ID: 17695453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
